These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 8397346)
1. Evidence for an involvement of the mu-type of opioid receptor in the modulation of learning. Aloyo VJ; Romano AG; Harvey JA Neuroscience; 1993 Jul; 55(2):511-9. PubMed ID: 8397346 [TBL] [Abstract][Full Text] [Related]
2. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related]
3. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides. Kiritsy-Roy JA; Marson L; Van Loon GR J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411 [TBL] [Abstract][Full Text] [Related]
4. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831 [TBL] [Abstract][Full Text] [Related]
5. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. Stewart PE; Hammond DL J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918 [TBL] [Abstract][Full Text] [Related]
6. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition. Liu-Chen LY; Yang HH; Li S; Adams JU J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074 [TBL] [Abstract][Full Text] [Related]
7. Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat. Wang XM; Yan JQ; Zhang KM; Mokha SS Brain Res; 1996 Nov; 739(1-2):235-43. PubMed ID: 8955943 [TBL] [Abstract][Full Text] [Related]
8. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution. May CN; Dashwood MR; Whitehead CJ; Mathias CJ Br J Pharmacol; 1989 Nov; 98(3):903-13. PubMed ID: 2556206 [TBL] [Abstract][Full Text] [Related]
9. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice. Suh HH; Tseng LF Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107 [TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant effects of mu (DAGO) and delta (DPDPE) enkephalins in rats. Tortella FC; Echevarria E; Robles L; Mosberg HI; Holaday JW Peptides; 1988; 9(5):1177-81. PubMed ID: 2854247 [TBL] [Abstract][Full Text] [Related]
11. Modulation of mu-mediated antitussive activity in rats by a delta agonist. Kamei J; Tanihara H; Kasuya Y Eur J Pharmacol; 1991 Oct; 203(1):153-6. PubMed ID: 1665789 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909 [TBL] [Abstract][Full Text] [Related]
13. mu-Opioid peptide modulation of cardiovascular and sympathoadrenal responses to stress. Marson L; Kiritsy-Roy JA; Van Loon GR Am J Physiol; 1989 Oct; 257(4 Pt 2):R901-8. PubMed ID: 2552846 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat. Tiseo PJ; Yaksh TL Eur J Pharmacol; 1993 May; 236(1):89-96. PubMed ID: 8391455 [TBL] [Abstract][Full Text] [Related]
15. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice. Heyman JS; Mosberg HI; Porreca F NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989 [TBL] [Abstract][Full Text] [Related]
16. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265 [TBL] [Abstract][Full Text] [Related]
17. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Mellon RD; Bayer BM Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057 [TBL] [Abstract][Full Text] [Related]
18. Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice. Kamei J; Iwamoto Y; Suzuki T; Nagase H; Misawa M; Kasuya Y Eur J Pharmacol; 1993 Mar; 234(1):117-20. PubMed ID: 8386091 [TBL] [Abstract][Full Text] [Related]
19. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro. Lupica CR; Proctor WR; Dunwiddie TV Brain Res; 1992 Oct; 593(2):226-38. PubMed ID: 1360320 [TBL] [Abstract][Full Text] [Related]
20. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum. Mitrovic I; Napier TC J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]